Articles Mentioning Pharmaceuticals Stocks

Results 1 - 10 of 915 : 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for Pharmaceuticals

Investing | April 16, 2014

Could This Small-Cap Biotech's Experimental Diabetes Drug Be a Game Changer?

This Texas-based biotech reported positive proof-of-concept results earlier this week and could be set to upend a number of big pharmaceutical companies if its experimental drug continues to deliver.

Investing | April 14, 2014

The Supreme Court Will Decide the Fate of a Blockbuster

Teva's day in court is coming.

Investing | April 14, 2014

Is This the Answer to Expensive Hepatitis-C Cures?

A dangerous new competitor for Gilead's miracle hepatitis-C drug, Sovaldi, may be on its way to market.

Investing | April 11, 2014

Merck Shouts "Me, Too!" But Will It Matter?

Merck (MRK) joins Gilead (GILD), Bristol-Myers (BMY), and AbbVie (ABBV) in the race to cure hepatitis C, but Merck may end up trailing the pack.

Investing | April 10, 2014

Today's Biotech Stocks to Watch: Bristol-Myers Squibb, Gilead Sciences and Merck & Co. Inc.

Morning movers in biotech and health care.

Investing | April 07, 2014

The AACR Annual Meeting May Move These 2 Stocks

The American Association for Cancer Research meeting shines a bright light on gene testing like that performed by Myriad, and on promising late stage breast cancer treatments, including Pfizer's palbociclib.

Investing | April 06, 2014

Partner Signed! Is Amarin's Turnaround Beginning?

Amarin Corporation plc (ADR) signed Japan's Kowa Pharmaceuticals as a marketing partner for Vascepa.

IRAs | March 31, 2014

3 Dividend Stocks for Your IRA

Time is running out for funding your IRA. Income investors should consider AbbVie, 3M, and Textainer.

Investing | March 31, 2014

Special Situation Alert: Time to Buy a Biotech Breakup?

Baxter announced it is splitting into two separate businesses

Investing | March 21, 2014

Can These Companies Bounce Back from Disappointing Sales?

Promising blood thinner Eliquis hasn't quite lived up to the hype surrounding it in its early life. Can Pfizer and Bristol-Myers Squibb turn things around?

Results 1 - 10 of 915 : 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for Pharmaceuticals